'Marketing surveillance' presentation slideshows

MT 100 for the Acute Treatment of Migraine

MT 100 for the Acute Treatment of Migraine. Peripheral & Central Nervous System Drugs Advisory Committee Rockville, MD August 4, 2005 POZEN, Inc. Chapel Hill, NC. MT 100 for the Acute Treatment of Migraine. Marshall Reese, PhD Executive Vice President Product Development

766 views • 60 slides

Authorised Representative Licensing

Authorised Representative Licensing. Presented By: Eng. Abdullah S. Al Dobaib. Registration and Licensing Executive Department ,MDS. Roadmap Premarket Approval Medical Device Sector Saudi Food and Drug Authority. MDS Roadmap. Market Authorization. E. License. MDNR Number. MDMA. MDEL.

773 views • 37 slides

WHO Technical Specifications and Pre-Qualification

WHO Technical Specifications and Pre-Qualification. UNICEF Vaccine Pre-Tender 2010-2012 Copenhagen Denmark 10 December 2008. Dr. Nora Dellepiane, Scientist WHO/IVB/QSS Carmen Rodriguez, Scientist WHO/IVB/QSS 10 December 2008. Outline of presentation. Introduction

802 views • 36 slides

398 views • 26 slides

Behavioral Studies Supporting Rx-to-OTC Switches

Behavioral Studies Supporting Rx-to-OTC Switches. Saul Shiffman, Ph.D. Professor, Psychology, Psychiatry & Pharmaceutical Sciences, University of Pittsburgh Senior Scientific Advisor, Pinney Associates Partner, JSR LLC Chief Science Officer, invivodata, inc. Agenda.

437 views • 25 slides

Today Sponge

Today Sponge. Charles J. Ganley, M.D. Director, Division of Over-the-Counter Drug Products. Regulatory Status. Today Sponge is an approved drug product Change in manufacturing facility for the drug product There are outstanding chemistry issues (manufacturing) to be resolved

183 views • 9 slides